Sign in
Recombinant activated factor VII treatment of retroperitoneal hematoma in a patient with renal failure receiving enoxaparin and clopidogrel
Journal article   Peer reviewed

Recombinant activated factor VII treatment of retroperitoneal hematoma in a patient with renal failure receiving enoxaparin and clopidogrel

Pharmacotherapy, Vol.27(5), pp.755-759
05/2007
PMID: 17461711

Abstract

Biological and medical sciences Medical sciences Nephrology. Urinary tract diseases Nephropathies. Renovascular diseases. Renal failure Pharmacology. Drug treatments Renal failure Urinary system involvement in other diseases. Miscellaneous Urinary tract. Prostate gland

Metrics

1 Record Views

Details